DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Comparison of Effect of cARvedilol Compared To bISoprolol on cenTral Pulse Pressure in Hypertension (ARTIST) Study

Information source: Jichi Medical University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hypertension

Intervention: carvedilol (Drug); bisoprolol (Drug)

Phase: Phase 4

Status: Recruiting

Sponsored by: Yoshio Matsui

Official(s) and/or principal investigator(s):
Kazuomi Kario, Principal Investigator, Affiliation: Jichi Medical University

Overall contact:
Yoshio Matsui, Phone: +81-285-58-7538, Email: yoshio@jichi.ac.jp

Summary

The purpose of this study is to compare of carvedilol, a vasodilating beta-blocker and bisoprolol, a beta1- selective beta-blocker for reducing the central pulse pressure and thereby left ventricular (LV) mass in never-treated hypertensive patients.

Clinical Details

Official title: Comparison of Effect of cARvedilol Compared To bISoprolol on cenTral Pulse Pressure in Hypertension (ARTIST) Study

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Change in central pulse pressure (pulse pressure amplification)

Secondary outcome: Change in LV mass index Changes in LV diastolic functions (E/Em, left atrium volume) Changes in urinary albumin excretion, B-type natriuretic peptide (BNP), HOMA-IR, and oxidative stress (urinary 8-isoprostane). Change in ambulatory BP

Detailed description: Carvedilol and bisoprolol are established beta-blockers for treating hypertension or chronic heart failure because these beta-blockers have cardio-protective effects. Recent studies have shown that the change in central pulse pressure is more closely associated with the change in cardiac load than the change in brachial pressure during hypertension treatment. Vasodilating beta-blockers may decrease central pulse pressure more than beta1- selective beta-blockers, because vasodilators reduced the magnitude of reflection wave by dilating peripheral muscular arteries. The investigators hypothesized that carvedilol, a vasodilating beta-blocker, would be more effective than bisoprolol, a beta1- selective beta-blocker in reducing central pulse pressure and thereby LV mass, through the reduction in the magnitude of reflection wave. The aim of the present study was to test this hypothesis in an active controlled, 2-arm parallel group comparison, prospective randomized open blinded end-point (PROBE) design study. At least 100 patients will be enrolled in each group and the follow up duration will be 48 weeks. The primary endpoint is to compare the change in central pulse pressure between the two groups.

Eligibility

Minimum age: 20 Years. Maximum age: 80 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Never-treated hypertensive subjects, aged 20-80 years (at the time of informed

consent), regardless of sex

- Clinic systolic BP/diastolic BP > 140/90 mmHg in a sitting position.

Exclusion Criteria:

- Beta−blocker contraindications(asthma, COPD…)

- Heart rate less than 55 bpm

- Subjects treated with nitrates

- Grade 3 hypertension (≥180 and/or ≥110 mmHg)

- Secondary hypertension or malignant hypertension

- History of heart failure, coronary artery disease, and stroke

- Arrhythmia

- Renal dysfunction (serum creatinine ≥2. 0 mg/dl)

- Hepatic dysfunction (AST and/or ALT ≥100 IU/l)

- A history of or a suspected malignant tumor within 5 years of enrollment

- Chronic inflammatory disease

- Pregnancy, childbearing potential with inadequate contraception, breast feeding

- Inability to give informed consent

Locations and Contacts

Yoshio Matsui, Phone: +81-285-58-7538, Email: yoshio@jichi.ac.jp

Iwakuni City Medical Center, Yamaguchi, Japan; Recruiting
Yoshio Matsui, Phone: +81-827-21-3211, Email: yoshio@jichi.ac.jp
Additional Information

Starting date: November 2010
Last updated: July 18, 2012

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017